This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carpick, B W Articles by Gariépy, J Search for Related Content PubMed PubMed Citation Articles by Carpick, B W Articles by Gariépy, J

The Escherichia coli heat-stable enterotoxin is a long-lived superagonist of guanylin.

Department of Medical Biophysics, University of Toronto, Ontario, Canada.

ABSTRACT

The mechanism by which bacterial heat-stable enterotoxins (ST I STA) cause diarrhea in humans and animals has been linked to the activation of an intestinal membrane-bound guanylate cyclase. Guanylin, a recently discovered rat intestinal peptide, is homologous in structure to ST I and can activate guanylate cyclase present on the human colonic carcinoma cell line T84. To directly test the mechanistic association of guanylate cyclase activation with diarrhea, we synthesized guanylin and a guanylin analog termed N9P10 guanylin and compared their biological activities with those of a synthetic ST I analog, termed ST Ib(6-18). We report that guanylin is able to inhibit the binding of a radiolabeled ST I analog to rat intestinal cells but causes diarrhea in infant mice only at doses at least 4 orders of magnitude higher than that of ST Ib(6-18). In contrast, N9P10 guanylin was enterotoxic in mice at much lower doses than guanylin but proved to be a weaker inhibitor of radiolabeled ST I than guanylin in the receptor binding assay. The pattern of guanylate cyclase activation observed for ST Ib(6-18) and the two guanylin analogs parallels the results observed in the receptor binding assay rather than those observed in the diarrheal assay. Treatment of guanylin with chymotrypsin or lumenal fluid derived from newborn mouse intestines resulted in a rapid loss of binding activity. Together, these results suggest that ST I enterotoxins may represent a class of long-lived superagonists of guanylin.

This article has been cited by other articles:

• Sindic, A., Schlatter, E. (2006). Cellular Effects of Guanylin and Uroguanylin. J. Am. Soc. Nephrol. 17: 607-616 [Abstract] [Full Text]  
• Pacha, J. (2000). Development of Intestinal Transport Function in Mammals. Physiol. Rev. 80: 1633-1667 [Abstract] [Full Text]  
• Forte, L. R., London, R. M., Freeman, R. H., Krause, W. J. (2000). Guanylin peptides: renal actions mediated by cyclic GMP. Am. J. Physiol. Renal Physiol. 278: F180-F191 [Abstract] [Full Text]  
• Forte, L. R., Eber, S. L., Fan, X., London, R. M., Wang, Y., Rowland, L. M., Chin, D. T., Freeman, R. H., Krause, W. J. (1999). Lymphoguanylin: Cloning and Characterization of a Unique Member of the Guanylin Peptide Family. Endocrinology 140: 1800-1806 [Abstract] [Full Text]  
• Fasano, A. (1999). Cellular microbiology: can we learn cell physiology from microorganisms?. Am. J. Physiol. Cell Physiol. 276: C765-C776 [Abstract] [Full Text]  
• Fonteles, M. C., Greenberg, R. N., Monteiro, H. S. A., Currie, M. G., Forte, L. R. (1998). Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am. J. Physiol. Renal Physiol. 275: F191-F197 [Abstract] [Full Text]  
• Nataro, J. P., Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201 [Abstract] [Full Text]